ATP and P2X3 Receptor in Chronic Cough

计划入组 20 人 · 首次发布于 2023 年 2 月 6 日

Neuroinflammatory Interactions of ATP and P2X3 Receptor in the Airways of Chronic Cough Patients

计划入组 18 人 · 首次发布于 2024 年 2 月 29 日

A Study to Assess the Efficacy of Gefapixant (MK-7264/AF-219), in Participants With Chronic Cough (MK-7264-006)

计划入组 24 人 · 首次发布于 2011 年 9 月 13 日

P2X3 purinergic receptor antagonists (Inspire)

Gefapixant(Lyfnua)

C₁₄H₁₉N₅O₄S · Rx

XZP-P283

Bayer Halts Development of Eliapixant Due to Safety Concerns

GSK Halts Camlipixant Development for Refractory Chronic Cough After Mixed Phase III Results

Addex GABAB PAM Candidate Shows Promising Anti-Cough Activity in Non-Human Primate Studies